edistride
astrazeneca ab - dapagliflozin propanediolo monoidrato - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - farmaci usati nel diabete - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. in aggiunta ad altri medicinali per il trattamento del diabete di tipo 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 e 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
omega 3 strides arcolab international
strides arcolab international ltd - omega-3-trigliceridi inclusi altri esteri e acidi - omega-3-trigliceridi inclusi altri esteri e acidi
dutasteride strides
strides pharma(cyprus)ltd - dutasteride - dutasteride
ibuprofene strides
strides pharma(cyprus)ltd - ibuprofene - ibuprofene
stridesmooth+ microcatheter
asahi intecc co., ltd - dispositivi per angiografia ed emodinamica - accessori altri
stride microcatetere
asahi intecc co., ltd - cateteri e microcateteri per embolizzazione periferica
oxaliplatino strides
mylan s.p.a. - oxaliplatino - oxaliplatino
etoricoxib generic partners
strides pharma(cyprus)ltd - etoricoxib - etoricoxib
tibolone generic partners
strides pharma(cyprus)ltd - tibolone - tibolone
kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - omeostasi del calcio - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.